Liquidia

Liquidia LQDA Stock

$57.53   1.413426%
Add to favorites
Market Cap
$5.18B
LOW - HIGH [24H]
$56.24 - $57.53
VOLUME [24H]
$72.58K
P/E Ratio
0
Earnings per share
-$1.05
ISIN
US53635D2027
Price   Prediction

Liquidia Price Chart

Sorry, that's all we've gotfor now...

Liquidia (LQDA) stock price today is 57.53 USD on Tech Market Small (+1.41% on the day). Updated .

Liquidia LQDA Financial and Trading Overview

Liquidia stock price 57.53 USD
Previous Close 56.37 USD
Open 56.49 USD
Bid 40.32 USD x 200
Ask 70.98 USD x 200
Day's Range 54.8 - 57.21 USD
52 Week Range 22.31 - 93.61 USD
Volume 1.8M USD
Avg. Volume 3.52M USD
Market Cap 5.11B USD
Beta (5Y Monthly) 0.414
PE Ratio (TTM) N/A
EPS (TTM) -1.05 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 66.13 USD

LQDA Valuation Measures

Enterprise Value 4.88B USD
Trailing P/E N/A
Forward P/E 16.515284
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 8.220013
Price/Book (mrq) N/A
Enterprise Value/Revenue 7.854
Enterprise Value/EBITDA 16.602

Trading Information

Liquidia Stock Price History

Beta (5Y Monthly) 0.414
52-Week Change 91.39%
S&P500 52-Week Change 10.51%
52 Week High 93.61 USD
52 Week Low 22.31 USD
50-Day Moving Average 48.5 USD
200-Day Moving Average 54.85 USD

LQDA Share Statistics

Avg. Volume (3 month) 3.52M USD
Avg. Daily Volume (10-Days) 2.6M USD
Shares Outstanding 90.11M
Float 65.81M
Short Ratio 2.53
% Held by Insiders 9.14%
% Held by Institutions 84.45%
Shares Short 17.51M
Short % of Float 24.06%
Short % of Shares Outstanding 19.42%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -15.14%
Operating Margin (ttm) 47.12%
Gross Margin 92.72%
EBITDA Margin 47.30%

Management Effectiveness

Return on Assets (ttm) 38.19%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 621.87M USD
Revenue Per Share (ttm) 7.04 USD
Quarterly Revenue Growth (yoy) 314.59%
Gross Profit (ttm) 576.63M USD
EBITDA 294.2M USD
Net Income Avi to Common (ttm) -94189000 USD
Diluted EPS (ttm) -1.05
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 396.09M USD
Total Cash Per Share (mrq) 4.4 USD
Total Debt (mrq) 168.76M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.019
Book Value Per Share (mrq) -0.283

Cash Flow Statement

Operating Cash Flow (ttm) 324.16M USD
Levered Free Cash Flow (ttm) 535.6M USD

Profile of Liquidia

Country United States
State NC
City Morrisville
Address 419 Davis Drive
ZIP 27560
Phone 919 328 4400
Website https://www.liquidia.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 216

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Q&A For Liquidia Stock

What is a current LQDA stock price?

Liquidia LQDA stock price today per share is 57.53 USD.

How to purchase Liquidia stock?

You can buy LQDA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Liquidia?

The stock symbol or ticker of Liquidia is LQDA.

Which industry does the Liquidia company belong to?

The Liquidia industry is Drug Manufacturers - Specialty & Generic.

How many shares does Liquidia have in circulation?

The max supply of Liquidia shares is 90.11M.

What is Liquidia Price to Earnings Ratio (PE Ratio)?

Liquidia PE Ratio is now.

What was Liquidia earnings per share over the trailing 12 months (TTM)?

Liquidia EPS is -1.05 USD over the trailing 12 months.

Which sector does the Liquidia company belong to?

The Liquidia sector is Healthcare.

Liquidia LQDA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24462.84 USD —
+0.55
1.95B USD — 24268.03 USD — 24538.78 USD — — 1.95B USD —
us US Tech Capital Market Composite RCMP US 109.88 USD —
+1.09
— — 108.35 USD — 109.94 USD — — — —
us US Tech Health Care IXHC US 1340.2 USD —
+0.55
— — 1325.21 USD — 1342.46 USD — — — —
$2.18T
Total marketcap
$71.41B
Total volume
BTC 58.24%   •   ETH 9.87%
Dominance
Select currency